BE870688A - Nouveaux derives de la 1-(4,4-bis-(4-fluorophenyl)-butyl)-4-phenoxy-1,2,3,6-tetrahydropyridine - Google Patents

Nouveaux derives de la 1-(4,4-bis-(4-fluorophenyl)-butyl)-4-phenoxy-1,2,3,6-tetrahydropyridine

Info

Publication number
BE870688A
BE870688A BE190651A BE190651A BE870688A BE 870688 A BE870688 A BE 870688A BE 190651 A BE190651 A BE 190651A BE 190651 A BE190651 A BE 190651A BE 870688 A BE870688 A BE 870688A
Authority
BE
Belgium
Prior art keywords
tetrahydropyridine
fluorophenyl
phenoxy
bis
butyl
Prior art date
Application number
BE190651A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BE870688A publication Critical patent/BE870688A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
BE190651A 1977-09-26 1978-09-22 Nouveaux derives de la 1-(4,4-bis-(4-fluorophenyl)-butyl)-4-phenoxy-1,2,3,6-tetrahydropyridine BE870688A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/836,867 US4134982A (en) 1977-09-26 1977-09-26 Antipsychotic 1-[4,4-Bis(4-fluorophenyl) butyl]-4-phenoxy-1,2,3,6-tetrahydropyridines

Publications (1)

Publication Number Publication Date
BE870688A true BE870688A (fr) 1979-01-15

Family

ID=25272918

Family Applications (1)

Application Number Title Priority Date Filing Date
BE190651A BE870688A (fr) 1977-09-26 1978-09-22 Nouveaux derives de la 1-(4,4-bis-(4-fluorophenyl)-butyl)-4-phenoxy-1,2,3,6-tetrahydropyridine

Country Status (9)

Country Link
US (1) US4134982A (fr)
JP (1) JPS6051466B2 (fr)
BE (1) BE870688A (fr)
CA (1) CA1103678A (fr)
DE (1) DE2840302A1 (fr)
ES (1) ES474081A1 (fr)
FR (1) FR2403995A1 (fr)
GB (1) GB2004875B (fr)
IT (1) IT1107766B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218456A (en) * 1978-07-10 1980-08-19 Warner-Lambert Company 1-(4-Fluorophenyl)-4-(1,2,3,6-tetrahydro-4-phenoxy-1-pyridinyl)-butanones
US4218455A (en) * 1978-07-10 1980-08-19 Warner-Lambert Company 1-(4-Fluorophenyl)-4-[1,2,3,6-tetrahydro-4-(phenylthio)-1-pyridinyl]-butanones and related sulfoxides and sulfones
IE49998B1 (en) * 1979-08-06 1986-01-22 Merrell Dow Pharma 4-(naphthalenyloxy)piperidine derivatives
GB2125781B (en) * 1982-08-20 1986-10-01 Kenneth Stephen Butler Water defluorinating bags
US4518713A (en) * 1984-04-13 1985-05-21 Hoechst-Roussel Pharmaceuticals Inc. Analgesic substituted-1-aminoalkylamino-4-aryloxypiperidines
ZA86171B (en) * 1985-01-16 1986-08-27 Hoffmann La Roche Polycyclic salts
GB8604789D0 (en) * 1986-02-26 1986-04-03 Shell Int Research Mixtures of octadienyl esters
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
GB0022556D0 (en) * 2000-09-14 2000-11-01 Oxoid Ltd Improvements in or relating to selective agents for biological cultures
JP2012036177A (ja) * 2010-07-16 2012-02-23 Sumitomo Chemical Co Ltd ピリジン化合物およびその有害生物防除用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3260723A (en) * 1963-08-27 1966-07-12 Parke Davis & Co 4-phenoxy piperidines; alpha4-phenoxy piperideines
US3927006A (en) * 1970-06-19 1975-12-16 Hoffmann La Roche Tetrahydropyridine derivatives

Also Published As

Publication number Publication date
FR2403995B1 (fr) 1981-06-12
JPS6051466B2 (ja) 1985-11-14
JPS5455576A (en) 1979-05-02
IT7851169A0 (it) 1978-09-20
GB2004875A (en) 1979-04-11
US4134982A (en) 1979-01-16
ES474081A1 (es) 1980-01-16
FR2403995A1 (fr) 1979-04-20
CA1103678A (fr) 1981-06-23
DE2840302A1 (de) 1979-04-05
IT1107766B (it) 1985-11-25
GB2004875B (en) 1982-03-10

Similar Documents

Publication Publication Date Title
IT1101613B (it) Derivati di 2,6-diamminonebularine ad azione farmacolosica
AR222481A1 (es) Procedimiento para obtener derivados de 1-(omega-alcanoiltio o omega-mercaptoalconoil)3,4-deshidroprolina
NO813334L (no) Nye 2,4-disubstituerte tiazolderivater.
BE868868A (fr) 1-thienyl- et furyl-2,3,4,5-tetrahydro-1h-3-benzazepines substituees
LV5511A3 (lv) Ú3H¾-imidazo-Ú5,1-a¾-1,2,3,5-tetrazin-4-ona atvasinajumu iegusanas panemiens
BE870688A (fr) Nouveaux derives de la 1-(4,4-bis-(4-fluorophenyl)-butyl)-4-phenoxy-1,2,3,6-tetrahydropyridine
IT1189393B (it) Composti di 1,4-diidropiridina
IT7823757A0 (it) Procedimento per la stabilizzazione di profumi.
IT1101612B (it) Procedimento per la produzione di 2,6-diamminonebularine
PL211919A1 (pl) Sposob wytwarzania nowych trans-4a-fenylo-2,3,4,4a,5,6,7,7a-oktahydro-1h-2-piryndyny
PL204641A1 (pl) Sposob wytwarzania pochodnych 1,3,5-triazyno-2,6-dionu
PT67511B (fr) Nouveaux derives de la piperidine
IT7831281A0 (it) Derivati di 2,3-i-cian-pirazina.
IT1102597B (it) Procedimento per la produzione di 2,3-dimetil-pentanale
BE862927A (fr) Nouvelles sulfonylhydrazones de 1,4-dioxo- et 4-oxoquinoxaline-2-carboxaldehyde
IT1158700B (it) Nuovi derivati 1h-1,2,4-triazolici 3,5-disostituiti
SE7811759L (sv) Derivat av 2,6-difenyl-3,7-dioxabicyklo-(3,3,0)-oktan-4,8-dion
IT7822883A0 (it) Procedimento per la preparazione di 3,5 di alogeno-aniline.
BE865569A (fr) Derives de l'imidazole.
PL205382A1 (pl) Sposob wytwarzania pochodnych 2h-1,2,4-triazynonu
DK319978A (da) Herbicid virksomme 1,2,4-triazin-5-an-derivater
UA8014A1 (uk) Спосіб отримання похідних 1,4-дігідропірідину
IT1190818B (it) Procedimento per la produzione di alfa-aminoderivati ciclici di 1-(3',4'-metilendiossifenil)etanolo
PL204779A1 (pl) Sposob wytwarzania nowych pochodnych dwu-n-tlenku 1,2,4-benzotriazyny
DK264082A (da) 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl-4-dibenzofuranon dibenzofuranolderivater

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: WARNER-LAMBERT CY

Effective date: 19850930